Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR

Fig. 1

High expression of LAPTM4B in LAC tissues and correlates with poor patients survival. a The average expression level of LAPTM4B in patients with LAC with gains (amplification) was higher than those without gains in The Cancer Genome Atlas (TCGA) database. Each bar represents the median values±quartile values. b Immunohistochemical analysis of LAPTM4B expression in LAC patients. a and b Negative expression of LAPTM4B. c and d Low expression of LAPTM4B. e and f High expression of LAPTM4B. a, c, e. Original magnification × 100; b, d, f. Original magnification × 200. C and D Kaplan-Meier overall survival and disease-free survival curves for patients with LAC stratified by high and low expression of LAPTM4B

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us